Some patients respond well to certain treatments while others do not. Some people become sick while others remain healthy. As doctors and patients we ask (or should ask): Why?
Wouldn't you rather prevent or preempt drug reactions, osteoporosis, breast cancer, or heart disease rather than treat it once it has occurred?
Genomic testing is one way by which we answer these questions. We then provide you with recommendations to impact your unique biochemical makeup to prevent the expression of genes that lead to illness or disease.
Our genomic testing encompasses:
CardioGenomic, DetoxiGenomic, EstroGenomic, ImmunoGenomic, NeuroGenomic, OsteoGenomic tests.
If you discover that you have an abnormal gene called a single nucleotide polymorphism (SNP), mercifully called a 'snip', you can do something about it. What is empowering is that you can use this information to prevent or preempt the expression of illness or disease.
Here are examples to highlight the utility of these tests.
The CardioGenomic test uncovers genetic susceptability to: high cholesterol risk, obesity, high blood pressure, coronary heart disease,heat attack, stroke, abnormal blood clotting, endothelial dysfunction.
Some people complain that drugs have an, "opposite effect on them" or people experience adverse drug reactions and wonder why. The DetoxiGenomic test looks to answer these questions and provide recommendations should you have an abnormal gene.
Currently, 1 in 8 women will develop breast cancer during the course of her lifetime. Since the vast majority of breast cancers are environmental, we can look to see how estrogen is metabolized, and look to see if there are any SNP's in estrogen metabolism via the EstroGenomic test. Based upon test results specific nutritional supplements and lifestyle changes are recommended that can greatly reduce your risk of developing a breast cancer should we discover that you have genetic predisposition (if you have a SNP or SNP's).
The ImmunoGenomic test looks at genes that modulate immune function and inflammation in your body. The test uncovers potential genetic susceptability to: asthma, certain cancers, infectious diseases, arthritis, heart disease, an infection that causes stomach ulcers, autoimmune diseases, allergy, bone inflammation, bone loss, and inflammatory bowel disease.
The NeuroGenomic test uncovers potential genetic susceptability to: mood disorders, detoxification capacity, developmental issues, neurodegenerative disorders.
The OsteoGenomic test uncovers potential genetic susceptability to: low bone mineral density, osteoporosis (substantial bone loss), osteopenia (mild bone loss), arthritis, and age-related bone fractures.
"The Methyl Cycle is the backbone of our physiology. It's functional status determines our resistance or susceptibility to environmental toxins and microbes. This is a confusing array of biochemistry, but suffice it to say, a defect at any one point in these interlocking cycles will inevitably affect the remaining pathways, and your overall health will then suffer. Methyl Cycle abnormalities explain why you are sick from environmental toxins while the guy next door is just fine, why you are autistic while your fraternal twin brother is not. While we cannot change your DNA, if we know your weak links we can create "nutritional workarounds" - we can supplement alternative pathways or withhold from your diet molecules that you cannot handle. If we do not address the Methyl Cycle abnormalities that underlie unexplained or chronic illness - the illnesses will remain chronic and unexplained, because it is the Methyl Cycle abnormalities that predisposed you to ill health." From Heartfixer.com website. For more information about this and other cycles: http://heartfixer.com/AMRI-Nutrigenomics.htm#MTHFR: %205,10-Methylenetetrahydrofolate%20Reductase%20(Þ%205-Methyl-Folate)
